NantKwest Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
350.00
59,104.00
294,218.00
198,921.00
128,152.00
74,149
Total Accounts Receivable
380.00
145.00
1,774.00
2,668.00
1,258.00
12,168
Other Current Assets
248.00
124.00
1,548.00
3,556.00
3,048.00
2,455
Total Current Assets
978.00
59,373.00
297,540.00
205,145.00
132,458.00
88,772
Net Property, Plant & Equipment
13.00
211.00
6,147.00
19,268.00
76,726.00
76,885
Total Investments and Advances
249.00
268.00
55,479.00
87,887.00
38,279.00
14,380
Intangible Assets
863.00
3.00
7,683.00
5,196.00
2,826.00
565
Other Assets
-
141.00
-
-
151.00
1,348
Total Assets
2,103.00
59,996.00
366,849.00
317,496.00
250,440.00
181,950
ST Debt & Current Portion LT Debt
-
-
-
534.00
618.00
Accounts Payable
1,501.00
1,131.00
2,085.00
4,045.00
5,865.00
Other Current Liabilities
1,145.00
753.00
4,063.00
7,974.00
14,385.00
Total Current Liabilities
2,646.00
1,884.00
6,148.00
12,553.00
20,868.00
Long-Term Debt
1,760.00
-
2,468.00
7,676.00
6,650.00
Deferred Taxes
-
-
1,165.00
996.00
498.00
Other Liabilities
592.00
521.00
1,073.00
2,853.00
3,580.00
Total Liabilities
4,998.00
2,405.00
10,854.00
24,078.00
31,596.00
Common Equity (Total)
2,895.00
57,591.00
355,995.00
293,418.00
218,844.00
Total Shareholders' Equity
2,895.00
57,591.00
355,995.00
293,418.00
218,844.00
Total Equity
2,895.00
57,591.00
355,995.00
293,418.00
218,844.00
Liabilities & Shareholders' Equity
2,103.00
59,996.00
366,849.00
317,496.00
250,440.00

About NantKwest

View Profile
Address
3530 John Hopkins Court
San Diego California 92121
United States
Employees -
Website http://www.nantkwest.com
Updated 07/08/2019
NantKwest, Inc. engages in the development of immunotherapies with a focus on harnessing the power of the innate immune system. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The firm operates through the following geographical segments: United States; Europe; and Other Non-U.